AN HISTONE DEACETYLASE INHIBITOR IN COMBINATION WITH A SIRTUIN ACTIVATOR AGENT FOR THE TREATMENT OF NEURODEGENERATIVEDISEASES AND TUMORS OR NEOPLASMS

摘要

The present invention relates to a pharmaceutical composition comprising at least one histone deacetylase inhibitor, and at least one sirtuin activator agent having the general formula described. Such composition is used as a medication to treat chronic neurodegenerative diseases, and/or in the treatment of tumours or neoplasms.